Related references
Note: Only part of the references are listed.Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation
K Suda et al.
JOURNAL OF IMMUNOLOGY (2004)
Functions of AP1 (Fos/Jun) in bone development
EF Wagner
ANNALS OF THE RHEUMATIC DISEASES (2002)
Regulation of mucosal dendritic cell function by receptor activator of NF-κB (RANK)/RANK ligand interactions:: Impact on tolerance induction
E Williamson et al.
JOURNAL OF IMMUNOLOGY (2002)
Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis
E Romas et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-κB ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvariae
P Palmqvist et al.
JOURNAL OF IMMUNOLOGY (2002)
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis
AR Pettit et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity
J Lam et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro
NJ Horwood et al.
JOURNAL OF IMMUNOLOGY (2001)
Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function
TJ Yun et al.
JOURNAL OF IMMUNOLOGY (2001)
Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection
YTA Teng et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
